Myron Holubiak
2023
In 2023, Myron Holubiak earned a total compensation of $1.6M as Executive Vice Chairman at Citius Pharmaceuticals, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,250 |
|---|---|
| Option Awards | $953,123 |
| Salary | $450,000 |
| Total | $1,594,373 |
Holubiak received $953.1K in option awards, accounting for 60% of the total pay in 2023.
Holubiak also received $191.3K in non-equity incentive plan and $450K in salary.
Rankings
In 2023, Myron Holubiak's compensation ranked 742nd out of 2,978 executives tracked by ExecPay. In other words, Holubiak earned more than 75.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 742 out of 2,978 | 75th |
Division Manufacturing | 424 out of 1,637 | 74th |
Major group Chemicals And Allied Products | 287 out of 906 | 68th |
Industry group Drugs | 281 out of 869 | 68th |
Industry Pharmaceutical Preparations | 186 out of 627 | 70th |
Source: SEC filing on January 26, 2024.
Holubiak's colleagues
We found two more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2023.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018